Back to Search
Start Over
Rapid response to ciclosporin in patients with Parthenium dermatitis: A preliminary study.
- Source :
- Contact Dermatitis (01051873); Feb2021, Vol. 84 Issue 2, p134-136, 3p
- Publication Year :
- 2021
-
Abstract
- Keywords: ciclosporin; Parthenium dermatitis; treatment EN ciclosporin Parthenium dermatitis treatment 134 136 3 01/28/21 20210201 NES 210201 I Parthenium hysterophorus i , a weed of the Compositae family, is the most common cause of airborne contact dermatitis in India.1 It is a chronic debilitating illness resulting in high morbidity. Ciclosporin, an anti-inflammatory and immunosuppressant, has been shown to be effective in two patients with I Parthenium i dermatitis.4 In this case series, we evaluated clinical efficacy and safety of ciclosporin in patients with parthenium dermatitis. Thus, ciclosporin appears to be an effective drug in treatment of patients with I Parthenium i dermatitis, particularly when corticosteroids and azathioprine are contraindicated. [Extracted from the article]
- Subjects :
- SKIN inflammation
TUMOR necrosis factors
Subjects
Details
- Language :
- English
- ISSN :
- 01051873
- Volume :
- 84
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Contact Dermatitis (01051873)
- Publication Type :
- Academic Journal
- Accession number :
- 148306250
- Full Text :
- https://doi.org/10.1111/cod.13697